448 related articles for article (PubMed ID: 31234428)
1. Alterations of Methionine Metabolism as Potential Targets for the Prevention and Therapy of Hepatocellular Carcinoma.
Pascale RM; Peitta G; Simile MM; Feo F
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31234428
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
3. Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression.
Frau M; Tomasi ML; Simile MM; Demartis MI; Salis F; Latte G; Calvisi DF; Seddaiu MA; Daino L; Feo CF; Brozzetti S; Solinas G; Yamashita S; Ushijima T; Feo F; Pascale RM
Hepatology; 2012 Jul; 56(1):165-75. PubMed ID: 22318685
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting
Simile MM; Peitta G; Tomasi ML; Brozzetti S; Feo CF; Porcu A; Cigliano A; Calvisi DF; Feo F; Pascale RM
Oncotarget; 2019 Apr; 10(29):2835-2854. PubMed ID: 31073374
[TBL] [Abstract][Full Text] [Related]
5. S-adenosylmethionine regulates apurinic/apyrimidinic endonuclease 1 stability: implication in hepatocarcinogenesis.
Tomasi ML; Iglesias-Ara A; Yang H; Ramani K; Feo F; Pascale MR; Martínez-Chantar ML; Mato JM; Lu SC
Gastroenterology; 2009 Mar; 136(3):1025-36. PubMed ID: 18983843
[TBL] [Abstract][Full Text] [Related]
6. Deregulation of methionine metabolism as determinant of progression and prognosis of hepatocellular carcinoma.
Pascale RM; Feo CF; Calvisi DF; Feo F
Transl Gastroenterol Hepatol; 2018; 3():36. PubMed ID: 30050996
[TBL] [Abstract][Full Text] [Related]
7. Methionine adenosyltransferases in liver cancer.
Murray B; Barbier-Torres L; Fan W; Mato JM; Lu SC
World J Gastroenterol; 2019 Aug; 25(31):4300-4319. PubMed ID: 31496615
[TBL] [Abstract][Full Text] [Related]
8. Diminished S-adenosylmethionine biosynthesis and its metabolism in a model of hepatocellular carcinoma is recuperated by an adenosine derivative.
Lozano-Rosas MG; Chávez E; Velasco-Loyden G; Domínguez-López M; Martínez-Pérez L; Chagoya De Sánchez V
Cancer Biol Ther; 2020; 21(1):81-94. PubMed ID: 31552788
[TBL] [Abstract][Full Text] [Related]
9. S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent.
Pascale RM; Simile MM; Calvisi DF; Feo CF; Feo F
Cells; 2022 Jan; 11(3):. PubMed ID: 35159219
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
[TBL] [Abstract][Full Text] [Related]
11. S-adenosyl-L-methionine modifies antioxidant-enzymes, glutathione-biosynthesis and methionine adenosyltransferases-1/2 in hepatitis C virus-expressing cells.
Lozano-Sepulveda SA; Bautista-Osorio E; Merino-Mascorro JA; Varela-Rey M; Muñoz-Espinosa LE; Cordero-Perez P; Martinez-Chantar ML; Rivas-Estilla AM
World J Gastroenterol; 2016 Apr; 22(14):3746-57. PubMed ID: 27076759
[TBL] [Abstract][Full Text] [Related]
12. Role of abnormal methionine metabolism in alcoholic liver injury.
Lu SC; Tsukamoto H; Mato JM
Alcohol; 2002 Jul; 27(3):155-62. PubMed ID: 12163143
[TBL] [Abstract][Full Text] [Related]
13. S-adenosylmethionine regulates dual-specificity mitogen-activated protein kinase phosphatase expression in mouse and human hepatocytes.
Tomasi ML; Ramani K; Lopitz-Otsoa F; Rodríguez MS; Li TW; Ko K; Yang H; Bardag-Gorce F; Iglesias-Ara A; Feo F; Pascale MR; Mato JM; Lu SC
Hepatology; 2010 Jun; 51(6):2152-61. PubMed ID: 20196119
[TBL] [Abstract][Full Text] [Related]
14. Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer.
Lu SC; Mato JM
Alcohol; 2005 Apr; 35(3):227-34. PubMed ID: 16054984
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of methionine adenosyltransferase genes influences the rate of growth of human hepatocellular carcinoma cells.
Cai J; Mao Z; Hwang JJ; Lu SC
Cancer Res; 1998 Apr; 58(7):1444-50. PubMed ID: 9537246
[TBL] [Abstract][Full Text] [Related]
16. Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-{kappa}B and Mat1A genes in the early stages of rat liver carcinogenesis.
Simile MM; Pagnan G; Pastorino F; Brignole C; De Miglio MR; Muroni MR; Asara G; Frau M; Seddaiu MA; Calvisi DF; Feo F; Ponzoni M; Pascale RM
Carcinogenesis; 2005 Feb; 26(2):417-27. PubMed ID: 15498786
[TBL] [Abstract][Full Text] [Related]
17. Methionine adenosyltransferases in cancers: Mechanisms of dysregulation and implications for therapy.
Maldonado LY; Arsene D; Mato JM; Lu SC
Exp Biol Med (Maywood); 2018 Jan; 243(2):107-117. PubMed ID: 29141455
[TBL] [Abstract][Full Text] [Related]
18. HuR/methyl-HuR and AUF1 regulate the MAT expressed during liver proliferation, differentiation, and carcinogenesis.
Vázquez-Chantada M; Fernández-Ramos D; Embade N; Martínez-Lopez N; Varela-Rey M; Woodhoo A; Luka Z; Wagner C; Anglim PP; Finnell RH; Caballería J; Laird-Offringa IA; Gorospe M; Lu SC; Mato JM; Martínez-Chantar ML
Gastroenterology; 2010 May; 138(5):1943-53. PubMed ID: 20102719
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-21-3p, a berberine-induced miRNA, directly down-regulates human methionine adenosyltransferases 2A and 2B and inhibits hepatoma cell growth.
Lo TF; Tsai WC; Chen ST
PLoS One; 2013; 8(9):e75628. PubMed ID: 24098708
[TBL] [Abstract][Full Text] [Related]
20. Role of promoter methylation in increased methionine adenosyltransferase 2A expression in human liver cancer.
Yang H; Huang ZZ; Zeng Z; Chen C; Selby RR; Lu SC
Am J Physiol Gastrointest Liver Physiol; 2001 Feb; 280(2):G184-90. PubMed ID: 11208539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
